Luminor Medical Technologies CEO: We’ll Get to Revenue Quickly and Turn a Profit Next Year

Share on Linkedin

Luminor Medical Technologies (TSXV: LMT) recently acquired a licence for all current and future cannabis commercial products from Jamaica BLU Ltd.


In this interview with SmallCapPower at the recent Formula 1 Capital Conference in Montreal, Luminor Medical Technologies (TSXV: LMT) CEO Christian Sauvageau discusses Luminor’s non-invasive diagnostic technology to screen for diabetes, as well as its recent acquisition of a licence for all current and future cannabis commercial products from Jamaica BLU Ltd.

Disclosure: Neither any of the principals at Small Cap Power, nor their family members, own shares in any of the companies mentioned above.

The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below: